GlassScriptPhysician profile
Keith M Rubin
NPI 1043348154
$882.92
in general payments reported to CMS, 2019-2025
14 companies · $40.35 in 2025
The $40.35 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $155 · 2021: $198 · 2022: $56.14 · 2023: $66.96 · 2024: $121 · 2025: $40.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $194.97 | 2020-2024 | Mounjaro, Zepbound |
| Amgen INC. | $132.79 | 2019-2025 | Otezla, Repatha, Repatha |
| Novo Nordisk INC | $113.82 | 2019-2021 | |
| Karl Storz Endoscopy-America | $105.83 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $60.57 | 2020-2024 | Airsupra |
| Novartis Pharmaceuticals Corporation | $57.78 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $47.35 | 2019 | |
| Pfizer INC. | $40.72 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $33.29 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.22 | 2019 | |
| Eisai INC. | $19.58 | 2020 | |
| Esperion Therapeutics, INC. | $17.94 | 2021 | |
| Abbott Laboratories | $16.18 | 2024 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $15.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.